Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Axon and RapidSOS partnering in real time data for first responders » 08:38
04/22/21
04/22
08:38
04/22/21
08:38
AXON

Axon

$149.79 /

-1.04 (-0.69%)

Axon and RapidSOS…

Axon and RapidSOS announced a partnership to provide emergency first responders and 911 telecommunicators access to critical emergency incident information from Axon devices being used by law enforcement officers. Through this partnership, Emergency Communication Centers across the U.S. will be eligible to access the location of officers, real-time alerts resulting from developing situations, and streaming video through Axon Respond devices such as Axon body-worn cameras, Axon Fleet in-car cameras, and Axon Air connected drones. Additionally, emergency intelligence data from more than 350 million connected devices recognized as RapidSOS Ready will be available to dispatchers and first responders via Axon Respond.

ShowHide Related Items >><<
AXON Axon
$149.79 /

-1.04 (-0.69%)

AXON Axon
$149.79 /

-1.04 (-0.69%)

02/26/21 Baird
Axon price target raised to $200 from $135 at Baird
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Axon downgraded to Neutral from Overweight at JPMorgan
AXON Axon
$149.79 /

-1.04 (-0.69%)

AXON Axon
$149.79 /

-1.04 (-0.69%)

Tuesday
Syndicate
Axon files automatic mixed securities shelf  17:01
04/20/21
04/20
17:01
04/20/21
17:01
AXON

Axon

$150.97 /

+0.47 (+0.31%)

 
ShowHide Related Items >><<
AXON Axon
$150.97 /

+0.47 (+0.31%)

AXON Axon
$150.97 /

+0.47 (+0.31%)

02/26/21 Baird
Axon price target raised to $200 from $135 at Baird
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Axon downgraded to Neutral from Overweight at JPMorgan
AXON Axon
$150.97 /

+0.47 (+0.31%)

AXON Axon
$150.97 /

+0.47 (+0.31%)

Over a month ago
Hot Stocks
Axon, Skydio partner on autonomous drones » 07:34
03/11/21
03/11
07:34
03/11/21
07:34
AXON

Axon

$141.25 /

-2.76 (-1.92%)

Axon and Skydio announced…

Axon and Skydio announced a strategic partnership to offer Skydio's autonomous drones to law enforcement and emergency responders via Axon's unmanned aircraft program, Axon Air. As a Skydio Elite Partner, Axon will be the exclusive reseller and digital evidence management partner of Skydio's products to public safety globally. In addition, the two companies are working on a joint product roadmap that, in the coming months, will lead to the seamless integration between Skydio drones and Axon Air, Axon Evidence, and Axon Respond

ShowHide Related Items >><<
AXON Axon
$141.25 /

-2.76 (-1.92%)

AXON Axon
$141.25 /

-2.76 (-1.92%)

02/26/21 Baird
Axon price target raised to $200 from $135 at Baird
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Axon downgraded to Neutral from Overweight at JPMorgan
AXON Axon
$141.25 /

-2.76 (-1.92%)

AXON Axon
$141.25 /

-2.76 (-1.92%)

Hot Stocks
Government of Ontario deploys Axon Evidence across public safety agencies » 10:32
03/03/21
03/03
10:32
03/03/21
10:32
AXON

Axon

$163.28 /

-2.85 (-1.72%)

Axon announced that the…

Axon announced that the Ministry of the Solicitor General of Ontario is deploying Axon's digital evidence management solution, Axon Evidence, to the Ontario Provincial Police and multiple municipal police services across Ontario. This modernization initiative will connect all Ontario justice sector partners and stakeholders, including the police, courts, crown attorneys, defence counsel and corrections. Axon Evidence is a Canadian cloud-based digital evidence platform that allows agencies and investigators to store, manage, transfer and share digital evidence across all public safety agencies. Axon was selected through the province's open and competitive procurement process for a provincial digital evidence management solution. As a part of this announcement, the Ministry will also be supporting public submission of digital evidence via Axon Citizen.

ShowHide Related Items >><<
AXON Axon
$163.28 /

-2.85 (-1.72%)

AXON Axon
$163.28 /

-2.85 (-1.72%)

02/26/21 Baird
Axon price target raised to $200 from $135 at Baird
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Axon downgraded to Neutral from Overweight at JPMorgan
AXON Axon
$163.28 /

-2.85 (-1.72%)

AXON Axon
$163.28 /

-2.85 (-1.72%)

Recommendations
Axon price target raised to $200 from $135 at Baird » 07:18
02/26/21
02/26
07:18
02/26/21
07:18
AXON

Axon

$160.15 /

-0.95 (-0.59%)

Baird analyst William…

Baird analyst William Power raised the firm's price target on Axon to $200 from $135 and keeps an Outperform rating on the shares. The analyst noted its raised guidance and recent results which were driven by Taser which netted the company's largest win in its history. He expects its revised guidance remains conservative but sees it supported by strong growth trends and its strong competitive position.

ShowHide Related Items >><<
AXON Axon
$160.15 /

-0.95 (-0.59%)

AXON Axon
$160.15 /

-0.95 (-0.59%)

02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Axon downgraded to Neutral from Overweight at JPMorgan
AXON Axon
$160.15 /

-0.95 (-0.59%)

AXON Axon
$160.15 /

-0.95 (-0.59%)

Earnings
Axon raises 2021 revenue view to $740M-$780M from $720M-$750M » 16:13
02/25/21
02/25
16:13
02/25/21
16:13
AXON

Axon

$159.71 /

-1.39 (-0.86%)

Consensus for FY21…

Consensus for FY21 revenue is $742.24M. Raises 2021 adjusted EBITDA view to $125M-$140M from $140M-$130M. Sees 2021 CapEx $65M-$70M.

ShowHide Related Items >><<
AXON Axon
$159.71 /

-1.39 (-0.86%)

AXON Axon
$159.71 /

-1.39 (-0.86%)

02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Axon downgraded to Neutral from Overweight at JPMorgan
AXON Axon
$159.71 /

-1.39 (-0.86%)

AXON Axon
$159.71 /

-1.39 (-0.86%)

Earnings
Axon reports Q4 non-GAAP EPS $1.00, consensus 36c » 16:11
02/25/21
02/25
16:11
02/25/21
16:11
AXON

Axon

$160.15 /

-0.95 (-0.59%)

Reports Q4 revenue $226M,…

Reports Q4 revenue $226M, consensus $180.96M. The company stated, "In 2020, we solidified the foundation for our next decade of growth. First and foremost, we served our customers, team members and communities during a global pandemic. At the same time, we secured our first Dispatch customer, established a solid foothold in the Federal market, launched our Respond platform and grew our international revenue by more than 70%. We are proud to have delivered a record $681M in revenue, representing 28% growth, $1.2B in contract bookings, and $221M in annual recurring revenue. We wrapped up the year with an exceptional Q4, highlighted by revenue growth of 32%, strong profitability and robust global demand for our TASER devices. The results showcase the leverage in our business model".

ShowHide Related Items >><<
AXON Axon
$160.15 /

-0.95 (-0.59%)

AXON Axon
$160.15 /

-0.95 (-0.59%)

02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Axon downgraded to Neutral from Overweight at JPMorgan
AXON Axon
$160.15 /

-0.95 (-0.59%)

Downgrade
Fly Intel: Top five analyst downgrades » 09:55
02/12/21
02/12
09:55
02/12/21
09:55
ALNY

Alnylam

$162.00 /

-3.17 (-1.92%)

, IRDM

Iridium

$47.04 /

+0.84 (+1.82%)

, FOLD

Amicus

$13.13 /

-5.63 (-30.01%)

, WSM

Williams-Sonoma

$125.50 /

-2.18 (-1.71%)

, AXON

Axon

$198.30 /

-5.325 (-2.62%)

Catch up on today's…

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alnylam (ALNY) downgraded to Neutral from Buy at Citi with analyst Joel Beatty believing share upside will be limited by a "growing appreciation by the Street of competitors' threats" to the company's ATTR business by both acoramidis and gene editing. 2. Iridium (IRDM) double downgraded to Underweight from Overweight at Barclays with analyst Mathieu Robilliard saying the stock price "has run above fundamentals." 3. Amicus (FOLD) downgraded to Neutral from Overweight at JPMorgan and Cantor Fitzgerald, and downgraded to Market Perform from Outperform at SVB Leerink. 4. Williams-Sonoma (WSM) downgraded to Perform from Outperform at Oppenheimer with analyst Brian Nagel saying while he remains upbeat towards longer-term fundamental prospects for Williams-Sonoma, the analyst is increasingly concerned in the near-term that now more elevated Street forecasts could prove too optimistic as broader trends in spending likely normalize and comparisons turn more challenging. 5. Axon (AXON) downgraded to Neutral from Overweight at JPMorgan with analyst Mark Strouse saying with the shares up 66% year-to-date, significantly outperforming peers, Axon "could trade sideways for a period." click here.

ShowHide Related Items >><<
WSM Williams-Sonoma
$125.50 /

-2.18 (-1.71%)

IRDM Iridium
$47.04 /

+0.84 (+1.82%)

FOLD Amicus
$13.13 /

-5.63 (-30.01%)

AXON Axon
$198.30 /

-5.325 (-2.62%)

ALNY Alnylam
$162.00 /

-3.17 (-1.92%)

ALNY Alnylam
$162.00 /

-3.17 (-1.92%)

02/12/21 Barclays
Alnylam price target raised to $196 from $162 at Barclays
02/12/21 Citi
Alnylam downgraded to Neutral from Buy at Citi
02/12/21 H.C. Wainwright
Alnylam price target raised to $235 from $225 at H.C. Wainwright
02/11/21 Piper Sandler
Alnylam product sales guidance of $610M-$660M 'strong,' says Piper Sandler
IRDM Iridium
$47.04 /

+0.84 (+1.82%)

02/12/21 Barclays
Barclays double downgrades Iridium with stock ahead of fundamentals
02/12/21 Barclays
Iridium downgraded to Underweight from Overweight at Barclays
02/08/21 Raymond James
Iridium downgraded to Market Perform from Outperform at Raymond James
02/08/21 Raymond James
Iridium downgraded to Market Perform from Outperform at Raymond James
FOLD Amicus
$13.13 /

-5.63 (-30.01%)

02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
02/12/21 Cantor Fitzgerald
Amicus downgraded to Neutral from Overweight at Cantor Fitzgerald
02/12/21 Citi
Amicus price target lowered to $16 from $27 at Citi
WSM Williams-Sonoma
$125.50 /

-2.18 (-1.71%)

02/12/21 Oppenheimer
Williams-Sonoma downgraded to Perform from Outperform at Oppenheimer
02/12/21 Oppenheimer
Williams-Sonoma downgraded to Perform from Outperform at Oppenheimer
02/01/21 UBS
Williams-Sonoma downgraded to Sell from Neutral at UBS
02/01/21 UBS
Williams-Sonoma downgraded to Sell from Neutral at UBS
AXON Axon
$198.30 /

-5.325 (-2.62%)

02/12/21 JPMorgan
Axon downgraded to Neutral from Overweight at JPMorgan
WSM Williams-Sonoma
$125.50 /

-2.18 (-1.71%)

IRDM Iridium
$47.04 /

+0.84 (+1.82%)

FOLD Amicus
$13.13 /

-5.63 (-30.01%)

ALNY Alnylam
$162.00 /

-3.17 (-1.92%)

FOLD Amicus
$13.13 /

-5.63 (-30.01%)

ALNY Alnylam
$162.00 /

-3.17 (-1.92%)

WSM Williams-Sonoma
$125.50 /

-2.18 (-1.71%)

FOLD Amicus
$13.13 /

-5.63 (-30.01%)

WSM Williams-Sonoma
$125.50 /

-2.18 (-1.71%)

FOLD Amicus
$13.13 /

-5.63 (-30.01%)

AXON Axon
$198.30 /

-5.325 (-2.62%)

Downgrade
Axon downgraded to Neutral from Overweight at JPMorgan » 07:49
02/12/21
02/12
07:49
02/12/21
07:49
AXON

Axon

$203.63 /

+15.715 (+8.36%)

JPMorgan analyst Mark…

JPMorgan analyst Mark Strouse downgraded Axon Enterprise to Neutral from Overweight with a price target of $179, up from $129. With the shares up 66% year-to-date, significantly outperforming peers, Axon "could trade sideways for a period," Strouse tells investors in a research note. The analyst's long-term thesis is unchanged as he expects "solid momentum" to continue within the weapons and Axon cloud businesses, and he believes traction with U.S. federal and/or international agencies could present upside to current forecasts. Strouse believes long-term investors should hold existing positions, "potentially buying on dips."

ShowHide Related Items >><<
AXON Axon
$203.63 /

+15.715 (+8.36%)

AXON Axon
$203.63 /

+15.715 (+8.36%)

Hot Stocks
Axon Enterprise Inc trading resumes  11:05
02/11/21
02/11
11:05
02/11/21
11:05
AXON

Axon

$197.76 /

+9.845 (+5.24%)

 
ShowHide Related Items >><<
AXON Axon
$197.76 /

+9.845 (+5.24%)

AXON Axon
$197.76 /

+9.845 (+5.24%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.